Inhibition of adjuvant-induced arthritis by 16 α-fluoro-5-androsten-17-one

Military Medicine

Volumn 167, Issue 2 SUPPL., 2002, Pages 60-63

  Schwartz, Arthur G ^a   Pashko, Laura L ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; FLUASTERONE; PRASTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; CANCER PREVENTION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG USE; ESTROGEN ACTIVITY; FEMALE; NONHUMAN; RAT;

EID: 0036177359     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/167.suppl_1.60     Document Type: Conference Paper

References (27)

1. Dehydroepi-androsterone and structural analogs: A new class of cancer chemopreventive agents
2. Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit
3. Reduction of atherosclerosis by administration of dehydroepiandrosterone
4. Inhibition of accelerated atherosclerosis with dehydroepiandrosterone in the heterotrophic rabbit model of cardiac transplantation
5. Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence
6. Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production
7. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol
8. Dehydroepiandrosterone: A potential signaling molecule for neocortical organization during development
9. Dehydroepiandrosterone (DHEA) AND DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity
10. On the specificity of steroid interaction with mammary gland glucose-6-phosphate dehydrogenase
11. Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation-selection process of experimental carcinogenesis
12. Mechanism of inhibition of growth of 3T3-L1 fibroblasts and their differentiation to adipocytes by dehydroepiandrosterone and related steroids: Role of glucose-6-phosphate dehydrogenase
13. Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone
14. Inhibition of growth of HeLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo- and deoxyribonucleosides
15. Inhibition of 12-0-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16α-fluoro-5-androsten-17-one and its reversal by deoxyribonucleosides
16. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
17. Novel dehydroepiandrosterone analogues with enhanced biological activity and reduced side-effects in mice and rats
18. Antihyperglycemic effect of dehydroepiandrosterone analogue 16α-fluoro-5-androsten-17-one in diabetic mice
19. High bioavailability of dehydroepiandrosterone administered percutaneous in the rat
20. NADPH-oxidase: An update
21. Dehydroepiandrosterone and 16α-Br epiandrosterone inhibit 12-0-tetradecanoylphorbol-13-acetate stimulation of superoxide radical production by human polymorphonuclear leukocytes
22. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts
23. Oxygen radicals as second messengers for expression of the monocyte chemoattract protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G: Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase
24. Reactive oxygen intermediates as apparently widely used messengers in activation of NF-KB transcription factor and HIV-1
25. Interleukin-1α mediates phorbol-ester-induced inflammation and epidermal hyperplasia
26. The actions of exogenous dehydroepiandrosterone in experimental animals and humans